These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34296940)

  • 1. Identification of serum microRNAs with differential expression between dogs with splenic masses and healthy dogs with histologically normal spleens.
    Grimes JA; Robinson KR; Bullington AM; Schmiedt JM
    Am J Vet Res; 2021 Aug; 82(8):659-666. PubMed ID: 34296940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
    Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
    BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast harmonic ultrasonography of splenic masses and associated liver nodules in dogs.
    Ivancić M; Long F; Seiler GS
    J Am Vet Med Assoc; 2009 Jan; 234(1):88-94. PubMed ID: 19119970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperferritinemia in dogs with splenic hemangiosarcoma.
    Chikazawa S; Hori Y; Hoshi F; Kanai K; Ito N; Higuchi S
    J Vet Med Sci; 2013 Nov; 75(11):1515-8. PubMed ID: 23803459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-phase helical computed tomography in dogs with solid splenic masses.
    Kutara K; Seki M; Ishigaki K; Teshima K; Ishikawa C; Kagawa Y; Edamura K; Nakayama T; Asano K
    J Vet Med Sci; 2017 Nov; 79(11):1870-1877. PubMed ID: 28993600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.
    Albonico F; Mortarino M; Avallone G; Gioia G; Comazzi S; Roccabianca P
    Vet Immunol Immunopathol; 2013 Sep; 155(1-2):117-23. PubMed ID: 23871213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011).
    Eberle N; von Babo V; Nolte I; Baumgärtner W; Betz D
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):250-60. PubMed ID: 22911256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of canine splenic hemangiosarcomas and hematomas with nodular lymphoid hyperplasia or siderotic nodules.
    Cole PA
    J Vet Diagn Invest; 2012 Jul; 24(4):759-62. PubMed ID: 22621950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonographic features of splenic hemangiosarcoma in dogs: 18 cases (1980-1986).
    Wrigley RH; Park RD; Konde LJ; Lebel JL
    J Am Vet Med Assoc; 1988 Apr; 192(8):1113-7. PubMed ID: 3286591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005).
    Hammond TN; Pesillo-Crosby SA
    J Am Vet Med Assoc; 2008 Feb; 232(4):553-8. PubMed ID: 18279091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vascular endothelial growth factor in dogs with haemangiosarcoma and haematoma.
    Frenz M; Kaup FJ; Neumann S
    Res Vet Sci; 2014 Oct; 97(2):257-62. PubMed ID: 25241388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.
    Heishima K; Mori T; Sakai H; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
    PLoS One; 2015; 10(9):e0137361. PubMed ID: 26335793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
    Wong S; Ehrhart EJ; Stewart S; Zismann V; Cawley J; Halperin R; Briones N; Richter K; Sivaprakasam K; Perdigones N; Contente-Cuomo T; Facista S; Trent JM; Murtaza M; Khanna C; Hendricks WPD
    PLoS One; 2022; 17(7):e0264986. PubMed ID: 35867969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985).
    Prymak C; McKee LJ; Goldschmidt MH; Glickman LT
    J Am Vet Med Assoc; 1988 Sep; 193(6):706-12. PubMed ID: 3192450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
    Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
    BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
    Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K
    Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
    Davies O; Taylor AJ
    Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
    Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
    PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASSOCIATIONS BETWEEN DUAL-PHASE COMPUTED TOMOGRAPHY FEATURES AND HISTOPATHOLOGIC DIAGNOSES IN 52 DOGS WITH HEPATIC OR SPLENIC MASSES.
    Jones ID; Lamb CR; Drees R; Priestnall SL; Mantis P
    Vet Radiol Ultrasound; 2016; 57(2):144-53. PubMed ID: 26763951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.